EGFR and glioblastoma: Moreover, large scale genomic studies extrapolated from The Cancer Genome Atlas (TCGA) have revealed various mutations on oncogene and/or onco-suppressor genes by subtyping GBM, including TP53, PTEN, Neurofibromin-1 and epidermal growth factor receptor (EGFR).